Sfoglia per Autore
Skin metastases in lung cancer: Analysis of a 10-year experience
2001-01-01 Ambrogi, V; Nofroni, I; Tonini, G; Mineo, Tc
Pulmonary metastasectomy: Might the type of resection affect survival?
2001-01-01 Mineo, Tc; Ambrogi, V; Tonini, G; Nofroni, I
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron
2001-01-01 Santini, D; Vincenzi, B; Fossati, C; D'Angelillo, Rm; Patti, G; Bianco, V; Avvisati, G; Tonini, G
Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer
2001-01-01 Ambrogi, V; Tonini, G; Mineo, Tc
Idiosyncratic reaction after oxaliplatin infusion
2001-01-01 Santini, D; Tonini, G; Salerno, A; Vincenzi, B; Patti, G; Battistoni, F; Dicuonzo, G; Labianca, R
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor
2002-01-01 VESPASIANI GENTILUCCI, U; Santini, D; Picardi, A; Vincenzi, B; Riva, E; Bianchi, A; Tonini, G
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
2002-01-01 Baldi, A; Groeger, Am; Esposito, V; Cassandro, R; Tonini, G; Battista, T; Di Marino, Mp; Vincenzi, B; Santini, M; Angelini, A; Rossiello, R; Baldi, F; Paggi, Mg
Tolerability of raltitrexed ('Tomudex') in elderly patients with colorectal cancer
2002-01-01 Romiti, A; Tonini, G; Santini, D; Di Seri, M; Masciangelo, R; Mezi, S; Veri, A; Santuari, L; Vincenzi, B; Brescia, A; Marchei, P; Frati, L; Tomao, S
Gemcitabine as single agent chemotherapy in elderly patients with stages III-IVnon-small cell lung cancer (NSCLC): A phase II study
2002-01-01 Bianco, V; Rozzi, A; Tonini, G; Santini, D; Magnolfi, E; Vincenzi, B; D'Angelillo, R; Marchei, P
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
2002-01-01 Cascinu, S; Graziano, F; Ferrau, F; Catalano, V; Massacesi, C; Santini, D; Silva, Rr; Barni, S; Zaniboni, A; Battelli, N; Siena, S; Giordani, P; Mari, D; Baldelli, Am; Antognoli, S; Maisano, R; Priolo, D; Pessi, Ma; Tonini, G; Rota, S; Labianca, R
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients
2002-01-01 Santini, D; Vincenzi, B; Avvisati, G; Dicuonzo, G; Battistoni, F; Gavasci, M; Salerno, A; Denaro, V; Tonini, G
Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count
2002-01-01 Tonini, G; Santini, D; Vincenzi, B; Dicuonzo, G; Salerno, A; Finolezzi, E; Avvisati, G
Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients
2002-01-01 Tonini, G.; Santini, D.; Vincenzi, B.; Borzomati, D.; Dicuonzo, G.; LA CESA, A.; Onori, N.; Coppola, R
Skin lesions in melanoma and Kaposi's sarcoma - Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression
2002-01-01 Santini, D; Tonini, G; Vincenzi, B; Murace, R; Ferranti, G; Baldi, A
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor
2002-01-01 Vespasiani Gentilucci, U; Santini, D; Picardi, A; Vincenzi, B; Riva, E; Bianchi, A; Tonini, G
The antineoplastic treatment in the elderly
2002-01-01 Vincenzi, B; Santini, D; Spoto, S; Finolezzi, E; D'Angelillo, Rm; La Cesa, A; Tonini, G
Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer
2003-01-01 Esposito, V; Baldi, A; Liuzzi, G; Tonini, G; Vincenzi, B; Persichetti, P; Santini, M; Ambrogi, V; Mineo, Tc; Montesarchio, V; Wolner, E; Baldi, F; Groeger, Am
Bisphosphonates: new antiangiogenic molecules in cancer treatment?
2003-01-01 Vincenzi, B; Santini, D; Rocci, L; Tonini, G
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
2003-01-01 Santini, D; Vincenzi, B; Tonini, G; Scarpa, S; Baldi, A
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study
2003-01-01 Fabi, A; Barduagni, M; Lauro, S; Portalone, L; Mauri, M; Marinis, F; Narduzzi, C; Tonini, G; Giampaolo, M; Pacetti, U; Paoloni, F; Cognetti, F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Skin metastases in lung cancer: Analysis of a 10-year experience | 1-gen-2001 | Ambrogi, V; Nofroni, I; Tonini, G; Mineo, Tc | |
Pulmonary metastasectomy: Might the type of resection affect survival? | 1-gen-2001 | Mineo, Tc; Ambrogi, V; Tonini, G; Nofroni, I | |
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron | 1-gen-2001 | Santini, D; Vincenzi, B; Fossati, C; D'Angelillo, Rm; Patti, G; Bianco, V; Avvisati, G; Tonini, G | |
Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer | 1-gen-2001 | Ambrogi, V; Tonini, G; Mineo, Tc | |
Idiosyncratic reaction after oxaliplatin infusion | 1-gen-2001 | Santini, D; Tonini, G; Salerno, A; Vincenzi, B; Patti, G; Battistoni, F; Dicuonzo, G; Labianca, R | |
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor | 1-gen-2002 | VESPASIANI GENTILUCCI, U; Santini, D; Picardi, A; Vincenzi, B; Riva, E; Bianchi, A; Tonini, G | |
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival | 1-gen-2002 | Baldi, A; Groeger, Am; Esposito, V; Cassandro, R; Tonini, G; Battista, T; Di Marino, Mp; Vincenzi, B; Santini, M; Angelini, A; Rossiello, R; Baldi, F; Paggi, Mg | |
Tolerability of raltitrexed ('Tomudex') in elderly patients with colorectal cancer | 1-gen-2002 | Romiti, A; Tonini, G; Santini, D; Di Seri, M; Masciangelo, R; Mezi, S; Veri, A; Santuari, L; Vincenzi, B; Brescia, A; Marchei, P; Frati, L; Tomao, S | |
Gemcitabine as single agent chemotherapy in elderly patients with stages III-IVnon-small cell lung cancer (NSCLC): A phase II study | 1-gen-2002 | Bianco, V; Rozzi, A; Tonini, G; Santini, D; Magnolfi, E; Vincenzi, B; D'Angelillo, R; Marchei, P | |
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD) | 1-gen-2002 | Cascinu, S; Graziano, F; Ferrau, F; Catalano, V; Massacesi, C; Santini, D; Silva, Rr; Barni, S; Zaniboni, A; Battelli, N; Siena, S; Giordani, P; Mari, D; Baldelli, Am; Antognoli, S; Maisano, R; Priolo, D; Pessi, Ma; Tonini, G; Rota, S; Labianca, R | |
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients | 1-gen-2002 | Santini, D; Vincenzi, B; Avvisati, G; Dicuonzo, G; Battistoni, F; Gavasci, M; Salerno, A; Denaro, V; Tonini, G | |
Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count | 1-gen-2002 | Tonini, G; Santini, D; Vincenzi, B; Dicuonzo, G; Salerno, A; Finolezzi, E; Avvisati, G | |
Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients | 1-gen-2002 | Tonini, G.; Santini, D.; Vincenzi, B.; Borzomati, D.; Dicuonzo, G.; LA CESA, A.; Onori, N.; Coppola, R | |
Skin lesions in melanoma and Kaposi's sarcoma - Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression | 1-gen-2002 | Santini, D; Tonini, G; Vincenzi, B; Murace, R; Ferranti, G; Baldi, A | |
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor | 1-gen-2002 | Vespasiani Gentilucci, U; Santini, D; Picardi, A; Vincenzi, B; Riva, E; Bianchi, A; Tonini, G | |
The antineoplastic treatment in the elderly | 1-gen-2002 | Vincenzi, B; Santini, D; Spoto, S; Finolezzi, E; D'Angelillo, Rm; La Cesa, A; Tonini, G | |
Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer | 1-gen-2003 | Esposito, V; Baldi, A; Liuzzi, G; Tonini, G; Vincenzi, B; Persichetti, P; Santini, M; Ambrogi, V; Mineo, Tc; Montesarchio, V; Wolner, E; Baldi, F; Groeger, Am | |
Bisphosphonates: new antiangiogenic molecules in cancer treatment? | 1-gen-2003 | Vincenzi, B; Santini, D; Rocci, L; Tonini, G | |
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer | 1-gen-2003 | Santini, D; Vincenzi, B; Tonini, G; Scarpa, S; Baldi, A | |
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study | 1-gen-2003 | Fabi, A; Barduagni, M; Lauro, S; Portalone, L; Mauri, M; Marinis, F; Narduzzi, C; Tonini, G; Giampaolo, M; Pacetti, U; Paoloni, F; Cognetti, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile